BETA: Please send your feedback!

Celgene

CELG:NAS

Biotechnology

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 3
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

About

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
 website

Headquarters

86 Morris Avenue
Summit, NJ 07901
1.908.673.9000

Executives

Name Title Gender
Isaac Blech Founder Male
Mark J. Alles Chief Executive Officer & Director Male
Sol J. Barer, PhD Founder Male
Robert J. Hugin, MBA Executive Chairman Male
Richard Cecil Eversfield Morgan Founder Male
Peter N. Kellogg, MBA Chief Financial Officer & Executive Vice President Male
Patrick E. Flanigan, III Vice President-Investor Relations Male
Joseph S. Camardo, MD Senior Vice President-Global Medical Affairs Male
Scott Andrew Smith President & Chief Operating Officer Male
David Stirling Founder Male
Gerald F. Masoudi Secretary, Executive VP & General Counsel Male
Rupert Vessey, PhD President-Research & Early Development Male

Mindful Investing Summary

  • Carbon Footprint
    3 N/A
  • Pollution Prevention
    1 N/A
  • Water Conservation
    3 N/A
  • Data & Privacy Protection
    — N/A
  • Consumer Health, Wellness & Safety
    3 N/A
  • Employee Ownership, Satisfaction, Benefits & Pay
    5 N/A
  • Workplace Health and Safety
    5 N/A
  • Integrity of Corporate Governance
    1 N/A
  • Ethical Practices
    5 N/A
  • Usage of Conflict Materials
    — N/A
  • Forced Labor
    — N/A
  • Diversity of Corporate Leadership
    4 N/A

Celgene - Competitors and Related Companies

How Celgene stacks up to its peers in the Biotechnology industry or with competing business segments.

Celgene

CELG:NAS

Biotechnology

—
MEGA cap
(—)
—
since start of 2021
—
  • 3
  • 1
  • 3
  • —
  • 3
  • 5
  • 5
  • 1
  • 5
  • —
  • —
  • 4
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Amgen

AMGN:NAS

Biotechnology

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 5
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Eli Lilly

LLY:NYS

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Gilead Sciences

GILD:NAS

Biotechnology

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Johnson & Johnson

JNJ:NYS

Pharmaceuticals: Major

—
MEGA cap
(—)
—
since start of 2021
—
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • —
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership

Alexion Pharmaceuticals

ALXN:NAS

Biotechnology

—
LARGE cap
(—)
—
since start of 2021
—
  • 5
  • 5
  • 4
  • 5
  • —
  • 4
  • 5
  • 4
  • —
  • —
  • —
  • 4
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data & Privacy Protection
  • Consumer Health, Wellness & Safety
  • Employee Ownership, Satisfaction, Benefits & Pay
  • Workplace Health and Safety
  • Integrity of Corporate Governance
  • Ethical Practices
  • Usage of Conflict Materials
  • Forced Labor
  • Diversity of Corporate Leadership